Based on recent data, Guardant Health, Inc. (GH) shows an Average True Range (ATR) of 5.89 and an Enterprise Value of 2.42B. Its average trading volume over the past 3 months is 2.07M, indicating liquidity. These fundamental metrics provide insight into GH's underlying financial health and market activity.
| ATR | 5.89 |
| Enterprise Value | 2.42B |
| Avg Vol (3 Months) | 2.07M |
| Avg Vol (10 Days) | 2.84M |
Guardant Health, Inc. (GH) technical indicators as of February 10, 2026: the SMA 20 is -4.8%, SMA 50 at -1.06%, and SMA 200 at 48.97%. The RSI 14 value is 46.09, suggesting its current momentum. These technical analysis signals help assess GH's price trends and potential future movements.
| SMA 20 | -4.8% |
| SMA 50 | -1.06% |
| SMA 200 | 48.97% |
| RSI 14 | 46.09 |
Guardant Health, Inc. (GH) stock performance overview as of February 10, 2026: The 52-week high is $120.74 (currently -12.75% below), and the 52-week low is $34.88 (currently 202.01% above). Over the past year, GH's performance is 207.88%, compared to the S&P 500's 9.6% change.
| 52-Week High | 120.74 |
| 52-Week High Chg | -12.75% |
| 52-Week Low | 34.88 |
| 52-Week Low Chg | +202.01% |
| S&P 500 52-Week Chg | 9.6% |
According to market data, Guardant Health, Inc. (GH) stock's recent performance metrics show that over the last month, GH is 17.85%, with a Year-to-Date (YTD) performance of 12.46%. Over the past year, the stock has seen a 207.88% change. These figures summarize GH's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 118 | 120.74 | 120.74 | 120.74 | 120.74 | 120.74 |
| Low | 97.52 | 97.52 | 89.68 | 51.44 | 34.88 | 97.31 |
| Performance | +6.79% | +17.85% | +75.48% | +151.69% | +207.88% | +12.46% |
According to current financial data, GH stock's P/E (TTM) ratio is -33.07, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for GH, including P/S (15.15), P/B (-37.21), and P/FCF (-52.13), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | GH | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -33.07 | -1.23 | 33.43 | 32.59 |
| P/S (TTM) | 15.15 | 3.71 | 19.05 | 5.98 |
| P/B (TTM) | -37.21 | 0 | -15.22 | 5.35 |
| P/FCF (TTM) | -52.13 | -7.45 | -119.31 | 31.38 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep